Skip to main content
NCD 280.13 · version 3

NCD 280.13: Transcutaneous Electrical Nerve Stimulators (TENS) - RETIRED

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 280.13

Benefit category
Durable Medical Equipment
Effective date
04/10/2023
Implemented 04/10/2023
Transmittal
Transmittal 11892
Versions published
3
Manual section
280
Medical and Surgical Supplies, NCD Manual (Pub. 100-03) chapter 1 part 4

TL;DR

NCD 280.13 sets Medicare's national policy for transcutaneous electrical nerve stimulators (tens) - retired under the benefit category "Durable Medical Equipment", effective 04/10/2023 and implemented 04/10/2023. 280.13 - Transcutaneous Electrical Nerve Stimulators (TENS) (RETIRED) It has been revised 2 times since publication and binds every Medicare Administrative Contractor nationally.

Indications and limitations of coverage

280.13 - Transcutaneous Electrical Nerve Stimulators (TENS) (RETIRED)

(Rev. 11892; Issued: 03-09-23; Effective: 04-10-23; Implementation: 04-10-23)

Please note section 280.13 has been removed from the NCD Manual and incorporated into NCD 160.27 effective June 8, 2012.

Text reproduced from the CMS Medicare Coverage Database record for NCD 280.13 version 3. View the original on cms.gov.

Local policies that build on this NCD

1 active Local Coverage Determination cites NCD 280.13 among its related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

How MACs bill NCD 280.13

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 1 current article in the Medicare Coverage Database names NCD 280.13, from 2 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

Contractors with articles that implement NCD 280.13
ContractorArticles
CGS Administrators, LLCA52520
Noridian Healthcare Solutions, LLCA52520

A52520: Transcutaneous Electrical Nerve Stimulators (TENS) - Policy Article

Article, effective 2023-01-01 · CGS Administrators, LLC (17013, 18003); Noridian Healthcare Solutions, LLC (16013, 19003) · CMS record

No covered diagnosis list. Local policy: L33802 Transcutaneous Electrical Nerve Stimulators (TENS).

Revision history

11/2012 - (Rev.149, Issued: 11-30-12, Effective: 06-08-12, Implementation: 01-07-13)

07/1995 - Provided coverage of TENS under the DME benefit. Effective date 08/07/1995. (TN 78)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 280.13

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 280.13

What does NCD 280.13 cover?

280.13 - Transcutaneous Electrical Nerve Stimulators (TENS) (RETIRED) The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 280.13 take effect?

The current version (3) is effective 04/10/2023, implemented 04/10/2023, published in transmittal 11892. CMS lists 3 versions of this NCD.

Does a Local Coverage Determination override NCD 280.13?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.